About the Product

Description


Ribziff 20 Tablet contains Rabeprazole, a potent proton pump inhibitor (PPI), with a dosage of 20mg per tablet. It is commonly prescribed to treat a range of conditions related to excessive stomach acid production. Rabeprazole works by inhibiting the proton pumps in the stomach lining, which are responsible for secreting gastric acid. By reducing acid production, Ribziff 20 Tablet helps in managing conditions like gastroesophageal reflux disease (GERD), gastric ulcers, duodenal ulcers, and Helicobacter pylori infections when used in combination therapy.

Ribziff 20 is an effective treatment for the relief of heartburn, acid reflux, and the prevention of ulcer formation. It is often recommended for patients with chronic acid reflux or those who are prone to stomach ulcers due to the prolonged use of certain medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs). In combination therapy, it can also help eradicate H. pylori bacteria when combined with appropriate antibiotics.

This medication is well-tolerated and offers fast relief for patients suffering from acid-related gastrointestinal issues. The therapeutic effect of Ribziff 20 ensures a significant reduction in symptoms, leading to improved quality of life and reducing the risk of damage to the esophagus or stomach lining caused by persistent acid reflux.

Possible side effects include headache, nausea, diarrhea, and stomach pain. If severe reactions such as allergic reactions occur, discontinue use and consult a healthcare provider.

Ribziff 20 Tablet is indicated for the treatment of GERD, gastric ulcers, duodenal ulcers, and as part of combination therapy for H. pylori eradication.

Ribziff 20 Tablet should be used under the supervision of a healthcare provider, especially in patients with liver or kidney disorders.

Store Ribziff 20 Tablet in a cool, dry place, away from direct sunlight, and keep it out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Rabeprazole 20mg Tablet in the PCD pharma franchise market?

Rabeprazole 20mg Tablet has strong demand in the gastroenterology, general medicine, and chronic care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on acid-peptic disorder and gastrointestinal care portfolios.

Why should medical distributors include Rabeprazole 20mg Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for acid-related gastrointestinal disorder management under medical supervision. Rabeprazole 20mg is a proton pump inhibitor (PPI) that effectively reduces excess stomach acid production Commonly prescribed for gastroesophageal reflux disease (GERD), acid reflux, heartburn, gastritis, peptic ulcers, erosive esophagitis, and other acid-peptic disorders Helps provide long-lasting relief from acidity and supports healing of the gastrointestinal lining Frequently used for both short-term symptom control and long-term management of chronic acid-related conditions Widely prescribed by gastroenterologists, physicians, and general practitioners This strengthens a comprehensive gastroenterology and acid-care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Rabeprazole 20mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from high prescription volumes, repeat demand, long-term therapy usage, reliable supply chain support, and attractive margins in the gastroenterology segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality product ranges, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.